Next Wednesday, July 5th, our team at Newel will share key insights on our DTx solution, Soturi, at the World Parkinson Congress in Barcelona!

Attendees can find our Chief Strategy Officer, Gerry Chillè, and our Clinical Trial Manager, Giovanni Gentile, presenting Soturi at the poster session “Evaluation of a Digital Therapeutics (DTx) for personalized medication and treatment plan optimization for people with Parkinson’s disease.”

Soturi leverages data collected from a wearable sensor using an algorithm-based decision-making method to optimize and personalize treatment for people living with Parkinson’s Disease (PD) while also delivering a host of useful digital services to the solution’s users. The research in Soturi’s approach to PD management is being funded by a generous grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF).

The 6th World Parkinson Congress (WPC 2023) will be held in Barcelona, Spain from July 4 – 7, 2023, providing an international forum for basic scientists, clinical researchers, health care professionals, people with Parkinson’s and others to come together under one roof to discuss, learn, and engage in debate around the latest scientific discoveries, medical and comprehensive care practices related to Parkinson’s disease.

To learn more about World Parkinson Congress, visit wpc2023.org